Interarm blood pressure differences in the women's interagency HIV study

Jason Lazar, Susan Holman, Howard L. Minkoff, Jack A. Dehovitz, Anjali Sharma

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hypertension has been reported in 8-32% of HIV-infected individuals. Large interarm blood pressure differences (IABPD) may cause misclassification of blood pressure (BP) status. The objectives of this study were to determine the magnitude and factors associated with IABPD in HIV-infected women and uninfected controls. Using automated devices, two BP recordings were measured and averaged from each arm in Brooklyn enrollees of the Women's Interagency HIV Study. Absolute IABPD was calculated for each patient. Among 335 subjects, 238 were HIV infected and 97 were uninfected. Mean systolic and diastolic IABPD were 6 ± 5 mm Hg and 4 ± 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD >10 mm Hg and 6% had systolic IABPD >20 mm Hg. Fifteen percent of subjects had diastolic IABPD >10 mm Hg. Interarm BP differences were not associated with HIV serostatus, CD4+ cell count, and use of highly active antiretroviral therapy. Systolic IABPD >20 mm Hg was associated with obesity (ORadj 5.37, 95% CI 1.47, 19.65), and LDL cholesterol above 160 (ORadj 9.12, 95% CI 2.53, 32.88). Right arm BP measurement resulted in 10% of subjects with high/uncontrolled BP. Bilateral arm BP measurement increased the yield to 15% (p < 0.001). In conclusion, systolic and diastolic IABPD are common and appear to be of clinically important magnitude. Systolic IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination is important to detect and manage hypertension as well as for accurate cardiovascular risk assessment.

Original languageEnglish (US)
Pages (from-to)695-700
Number of pages6
JournalAIDS Research and Human Retroviruses
Volume24
Issue number5
DOIs
StatePublished - May 1 2008
Externally publishedYes

Fingerprint

HIV
Blood Pressure
Hypertension
Blood Pressure Determination
Highly Active Antiretroviral Therapy
CD4 Lymphocyte Count
LDL Cholesterol
Obesity
Equipment and Supplies

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Interarm blood pressure differences in the women's interagency HIV study. / Lazar, Jason; Holman, Susan; Minkoff, Howard L.; Dehovitz, Jack A.; Sharma, Anjali.

In: AIDS Research and Human Retroviruses, Vol. 24, No. 5, 01.05.2008, p. 695-700.

Research output: Contribution to journalArticle

Lazar, Jason ; Holman, Susan ; Minkoff, Howard L. ; Dehovitz, Jack A. ; Sharma, Anjali. / Interarm blood pressure differences in the women's interagency HIV study. In: AIDS Research and Human Retroviruses. 2008 ; Vol. 24, No. 5. pp. 695-700.
@article{b5efabea60a246b2a68d72c68488b3f7,
title = "Interarm blood pressure differences in the women's interagency HIV study",
abstract = "Hypertension has been reported in 8-32{\%} of HIV-infected individuals. Large interarm blood pressure differences (IABPD) may cause misclassification of blood pressure (BP) status. The objectives of this study were to determine the magnitude and factors associated with IABPD in HIV-infected women and uninfected controls. Using automated devices, two BP recordings were measured and averaged from each arm in Brooklyn enrollees of the Women's Interagency HIV Study. Absolute IABPD was calculated for each patient. Among 335 subjects, 238 were HIV infected and 97 were uninfected. Mean systolic and diastolic IABPD were 6 ± 5 mm Hg and 4 ± 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD >10 mm Hg and 6{\%} had systolic IABPD >20 mm Hg. Fifteen percent of subjects had diastolic IABPD >10 mm Hg. Interarm BP differences were not associated with HIV serostatus, CD4+ cell count, and use of highly active antiretroviral therapy. Systolic IABPD >20 mm Hg was associated with obesity (ORadj 5.37, 95{\%} CI 1.47, 19.65), and LDL cholesterol above 160 (ORadj 9.12, 95{\%} CI 2.53, 32.88). Right arm BP measurement resulted in 10{\%} of subjects with high/uncontrolled BP. Bilateral arm BP measurement increased the yield to 15{\%} (p < 0.001). In conclusion, systolic and diastolic IABPD are common and appear to be of clinically important magnitude. Systolic IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination is important to detect and manage hypertension as well as for accurate cardiovascular risk assessment.",
author = "Jason Lazar and Susan Holman and Minkoff, {Howard L.} and Dehovitz, {Jack A.} and Anjali Sharma",
year = "2008",
month = "5",
day = "1",
doi = "10.1089/aid.2007.0237",
language = "English (US)",
volume = "24",
pages = "695--700",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Interarm blood pressure differences in the women's interagency HIV study

AU - Lazar, Jason

AU - Holman, Susan

AU - Minkoff, Howard L.

AU - Dehovitz, Jack A.

AU - Sharma, Anjali

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Hypertension has been reported in 8-32% of HIV-infected individuals. Large interarm blood pressure differences (IABPD) may cause misclassification of blood pressure (BP) status. The objectives of this study were to determine the magnitude and factors associated with IABPD in HIV-infected women and uninfected controls. Using automated devices, two BP recordings were measured and averaged from each arm in Brooklyn enrollees of the Women's Interagency HIV Study. Absolute IABPD was calculated for each patient. Among 335 subjects, 238 were HIV infected and 97 were uninfected. Mean systolic and diastolic IABPD were 6 ± 5 mm Hg and 4 ± 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD >10 mm Hg and 6% had systolic IABPD >20 mm Hg. Fifteen percent of subjects had diastolic IABPD >10 mm Hg. Interarm BP differences were not associated with HIV serostatus, CD4+ cell count, and use of highly active antiretroviral therapy. Systolic IABPD >20 mm Hg was associated with obesity (ORadj 5.37, 95% CI 1.47, 19.65), and LDL cholesterol above 160 (ORadj 9.12, 95% CI 2.53, 32.88). Right arm BP measurement resulted in 10% of subjects with high/uncontrolled BP. Bilateral arm BP measurement increased the yield to 15% (p < 0.001). In conclusion, systolic and diastolic IABPD are common and appear to be of clinically important magnitude. Systolic IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination is important to detect and manage hypertension as well as for accurate cardiovascular risk assessment.

AB - Hypertension has been reported in 8-32% of HIV-infected individuals. Large interarm blood pressure differences (IABPD) may cause misclassification of blood pressure (BP) status. The objectives of this study were to determine the magnitude and factors associated with IABPD in HIV-infected women and uninfected controls. Using automated devices, two BP recordings were measured and averaged from each arm in Brooklyn enrollees of the Women's Interagency HIV Study. Absolute IABPD was calculated for each patient. Among 335 subjects, 238 were HIV infected and 97 were uninfected. Mean systolic and diastolic IABPD were 6 ± 5 mm Hg and 4 ± 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD >10 mm Hg and 6% had systolic IABPD >20 mm Hg. Fifteen percent of subjects had diastolic IABPD >10 mm Hg. Interarm BP differences were not associated with HIV serostatus, CD4+ cell count, and use of highly active antiretroviral therapy. Systolic IABPD >20 mm Hg was associated with obesity (ORadj 5.37, 95% CI 1.47, 19.65), and LDL cholesterol above 160 (ORadj 9.12, 95% CI 2.53, 32.88). Right arm BP measurement resulted in 10% of subjects with high/uncontrolled BP. Bilateral arm BP measurement increased the yield to 15% (p < 0.001). In conclusion, systolic and diastolic IABPD are common and appear to be of clinically important magnitude. Systolic IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination is important to detect and manage hypertension as well as for accurate cardiovascular risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=44349145056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349145056&partnerID=8YFLogxK

U2 - 10.1089/aid.2007.0237

DO - 10.1089/aid.2007.0237

M3 - Article

VL - 24

SP - 695

EP - 700

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 5

ER -